{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:54:41Z","timestamp":1790621681013,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000374","name":"British Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HC Roscoe Award"},{"name":"SPARKS Medical Research, United Kingdom","award":["12LIV01"],"award-info":[{"award-number":["12LIV01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.antiviral.2014.12.008","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T11:00:51Z","timestamp":1418468451000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection"],"prefix":"10.1016","volume":"114","author":[{"given":"Muhammad S.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Mahallawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nav","family":"Upile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hoschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.antiviral.2014.12.008_b0080","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jinf.2014.01.013","article-title":"Immune responses to pneumococcal pilus RrgA and RrgB antigens and their relationship with pneumococcal carriage in humans","volume":"68","author":"Ahmed","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2014.12.008_b0045","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1073\/pnas.78.12.7639","article-title":"Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus","volume":"78","author":"Air","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.antiviral.2014.12.008_b0070","doi-asserted-by":"crossref","first-page":"e17074","DOI":"10.1371\/journal.pone.0017074","article-title":"Age-specific incidence of A\/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation","volume":"6","author":"Baguelin","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.antiviral.2014.12.008_b0110","first-page":"2616","article-title":"Final analysis of Netherlands avian influenza outbreaks reveals much higher levels of transmission to humans than previously thought","volume":"10","author":"Bosman","year":"2005","journal-title":"Euro Surveill."},{"issue":"5","key":"10.1016\/j.antiviral.2014.12.008_b0030","first-page":"1663","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J. Clin. Invest. [Research Support, Non-U.S. Gov\u2019t]"},{"issue":"6044","key":"10.1016\/j.antiviral.2014.12.008_b0040","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.12.008_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4172\/1747-0862.1000055","article-title":"The human transmembrane protease serine 2 is necessary for the production of group 2 influenza A virus pseudotypes","volume":"7","author":"Ferrara","year":"2013","journal-title":"J. Mol. Genet. Med."},{"issue":"10","key":"10.1016\/j.antiviral.2014.12.008_b0025","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.antiviral.2014.12.008_b0115","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.it.2011.08.007","article-title":"Targeting B cell responses in universal influenza vaccine design.","volume":"32","author":"Kaur","year":"2011","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.antiviral.2014.12.008_b0005","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/JVI.02184-09","article-title":"Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses","volume":"84","author":"Krause","year":"2010","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.antiviral.2014.12.008_b0100","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10","key":"10.1016\/j.antiviral.2014.12.008_b0020","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1128\/JVI.03547-12","article-title":"Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses","volume":"87","author":"Mahallawi","year":"2013","journal-title":"J. Virol."},{"issue":"9720","key":"10.1016\/j.antiviral.2014.12.008_b0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(09)62126-7","article-title":"Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study","volume":"375","author":"Miller","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.antiviral.2014.12.008_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2014.12.008_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4172\/1747-0862.1000056","article-title":"The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses","volume":"7","author":"Molesti","year":"2013","journal-title":"J. Mol. Genet. Med."},{"issue":"5","key":"10.1016\/j.antiviral.2014.12.008_b0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/mBio.00150-11","article-title":"Why do influenza virus subtypes die out? A hypothesis","volume":"2","author":"Palese","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2014.12.008_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","author":"Pica","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2014.12.008_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.1999.tb01326.x","article-title":"Induction of CD8+ T cells using heterologous prime-boost immunisation strategies","volume":"170","author":"Schneider","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2014.12.008_b0060","unstructured":"Smith G.E., et al., 1998. Method for Producing Influenza Hemagglutinin Multivalent Vaccines Using Baculovirus. MG-PMC, LLC, assignee. U.S. Patent 5,762,939 (09 Jun. 1998)."},{"issue":"5665","key":"10.1016\/j.antiviral.2014.12.008_b0055","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.1093373","article-title":"Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus","volume":"303","author":"Stevens","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.antiviral.2014.12.008_b0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"Temperton","year":"2007","journal-title":"Influenza Other Respir. Viruses"},{"issue":"11","key":"10.1016\/j.antiviral.2014.12.008_b0050","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1073\/pnas.1116200109","article-title":"A distinct lineage of influenza A virus from bats","volume":"109","author":"Tong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.antiviral.2014.12.008_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5976","key":"10.1016\/j.antiviral.2014.12.008_b0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1126\/science.1186430","article-title":"Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus","volume":"328","author":"Xu","year":"2010","journal-title":"Science"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:53:32Z","timestamp":1537995212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":24,"alternative-id":["S0166354214003593"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}